About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 690 trials

CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementThis randomized phase III trial studies two different schedules of zoledronic acid to compare how well they work in reducing bone-related complications in patients with breast…NCT00869206·Fairbanks, Alaska and 503 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerThis study is researching an investigational drug called REGN4336 both alone or together with another investigational drug called REGN5678.NCT05125016·Palo Alto, California and 13 others

CompletedMulti-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced CancerBackground: ETBX-011, ETBX-061, and ETBX-051 are cancer vaccines. Their goal is to teach the immune system to target and kill cancer cells.NCT03384316·Bethesda, Maryland

CompletedPROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThis randomized phase II trial studies how well PROSTVAC (prostate-specific antigen \[PSA\]-TRICOM) works in preventing disease progression in patients with prostate cancer…NCT02326805·Los Angeles, California and 6 others

RecruitingSacral Neuromodulation for Male Overactive Bladder (MOAB)To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.NCT06511141·Birmingham, Alabama and 22 others

CompletedPACCT: Partnering Around Cancer Clinical TrialsThis research has the overall goal of increasing rates at which African American and White men with prostate cancer make an informed decision to participate in a cancer clinical…NCT02906241·Baltimore, Maryland and 1 other

CompletedVaccine Therapy in Treating Patients With Recurrent Prostate CancerThis phase II trial is studying how well vaccine therapy works in treating patients with recurrent prostate cancer.NCT00109811·Baltimore, Maryland

CompletedCholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate CancerThis randomized phase II trial studies cholecalciferol and genistein compared to placebo in treating patients with early stage prostate cancer.NCT01325311·Birmingham, Alabama and 10 others

TerminatedDN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])The primary objective of this study is: * To evaluate the effect of DN-101 in combination with docetaxel (ASCENT regimen) on survival in metastatic androgen-independent prostate…NCT00273338·Birmingham, Alabama and 221 others

RecruitingThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following…NCT06520345·Orange, California and 32 others

Active not recruitingStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsPhase 2 open-label, single-arm clinical trial evaluating the efficacy and safety of neoadjuvant olaparib + LHRH agonist administered for 6 months prior to radical prostatectomy…NCT05498272·La Jolla, California and 5 others

TerminatedKetoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerRATIONALE: Ketoconazole may suppress the production of hormones and may interfere in the growth of prostate cancer cells.NCT00019695·Bethesda, Maryland

CompletedA Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerThe purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after…NCT04100018·Mobile, Alabama and 292 others

CompletedVaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerRATIONALE: Vaccines made from prostate cancer cells may make the body build an immune response to kill tumor cells.NCT00020254·Bethesda, Maryland

TerminatedA Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerThis is an open label, non-randomized, Phase I, dose escalation/dose expansion study of PCUR-101 in combination with androgen suppression therapy in the patients with metastatic…NCT03137758·Baltimore, Maryland and 2 others

TerminatedSunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyThis study will compare the safety and efficacy of sunitinib in combination with prednisone versus placebo and prednisone in patients that have metastatic castration-resistant…NCT00676650·Decatur, Alabama and 204 others

CompletedA Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateA 2-part, Phase 1-2, open-label, parallel group, randomized study in patients with Castration-Resistant Prostate Cancer (CRPC) who are no longer responding to treatment with…NCT01685268·Los Angeles, California and 31 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedInfluence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical TrialsBackground: A cancer diagnosis is a threat to life and bodily integrity. This can cause people with cancer to experience traumatic stress.NCT02948413·Bethesda, Maryland

CompletedA Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerThe purpose of this dose escalation study is to determine the Maximum Tolerated Dose (MTD) and the recommended Phase 2 dose of ASG-5ME in subjects with castration-resistant…NCT01228760·Baltimore, Maryland and 3 others

PreviousPage 3 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma